BACKGROUND: CRF02_AG is the predominant HIV strain circulating in West and West Central Africa. The aim of this study was to test whether this predominance is associated with a higher in vitro replicative fitness relative to parental subtype A and G viruses. Primary HIV-1 isolates (10 CRF02_AG, 5 subtype A and 5 subtype G) were obtained from a well-described Cameroonian cohort. Growth competition experiments were carried out at equal multiplicity of infection in activated T cells and monocyte-derived dendritic cells (MO-DC) in parallel. RESULTS: Dual infection/competition experiments in activated T cells clearly indicated that CRF02_AG isolates had a significant replication advantage over the subtype A and subtype G viruses. The higher fitn...
AbstractIntroductionLong-term natural history cohorts of HIV-1 in the absence of treatment provide t...
Background: The HIV pandemic disseminated globally from Central West Africa, beginning in the second...
In preparation for vaccine trials, HIV-1 genetic diversity was surveyed between 2002 and 2006 throug...
Background: CRF02_AG is the predominant HIV strain circulating in West and West Central Africa. The ...
BACKGROUND: Increased understanding of the genetic diversity of HIV-1 is challenging but important i...
Doctoral Degree. University of KwaZulu-Natal, Durban.The HIV-1 epidemic in sub-Saharan Africa is het...
BACKGROUND: The HIV-1 epidemic in sub-Saharan Africa is heterogeneous with diverse unevenly distribu...
AbstractThe genetic diversity of group M HIV-1 is highest in west central Africa. Blood samples from...
Increased understanding of the genetic diversity of HIV-1 is challenging but important in the develo...
AbstractIn Yaounde, Cameroon, HIV-1 group-specific V3 serology on 1469 HIV-positive samples collecte...
This study analyzed the distribution and prevalence of HIV-1 subtypes, multiplicity of HIV-1 infecti...
Human immunodeficiency virus type 1 (HIV-1) emerged in the human population shortly after the turn o...
The genetic diversity of group M HIV-1 is highest in west central Africa. Blood samples from four lo...
The genetic diversity of group M HIV-1 is highest in west central Africa. Blood samples from four lo...
We have developed and validated an oligonucleotide probe hybridization assay for human immunodeficie...
AbstractIntroductionLong-term natural history cohorts of HIV-1 in the absence of treatment provide t...
Background: The HIV pandemic disseminated globally from Central West Africa, beginning in the second...
In preparation for vaccine trials, HIV-1 genetic diversity was surveyed between 2002 and 2006 throug...
Background: CRF02_AG is the predominant HIV strain circulating in West and West Central Africa. The ...
BACKGROUND: Increased understanding of the genetic diversity of HIV-1 is challenging but important i...
Doctoral Degree. University of KwaZulu-Natal, Durban.The HIV-1 epidemic in sub-Saharan Africa is het...
BACKGROUND: The HIV-1 epidemic in sub-Saharan Africa is heterogeneous with diverse unevenly distribu...
AbstractThe genetic diversity of group M HIV-1 is highest in west central Africa. Blood samples from...
Increased understanding of the genetic diversity of HIV-1 is challenging but important in the develo...
AbstractIn Yaounde, Cameroon, HIV-1 group-specific V3 serology on 1469 HIV-positive samples collecte...
This study analyzed the distribution and prevalence of HIV-1 subtypes, multiplicity of HIV-1 infecti...
Human immunodeficiency virus type 1 (HIV-1) emerged in the human population shortly after the turn o...
The genetic diversity of group M HIV-1 is highest in west central Africa. Blood samples from four lo...
The genetic diversity of group M HIV-1 is highest in west central Africa. Blood samples from four lo...
We have developed and validated an oligonucleotide probe hybridization assay for human immunodeficie...
AbstractIntroductionLong-term natural history cohorts of HIV-1 in the absence of treatment provide t...
Background: The HIV pandemic disseminated globally from Central West Africa, beginning in the second...
In preparation for vaccine trials, HIV-1 genetic diversity was surveyed between 2002 and 2006 throug...